TCL Archive Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation April 28, 2006
TCL Archive FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer April 29, 1988
TCL Archive Waxman Compromise Bill Clears House; Centers Line Item Traded For Guarantee Of Minimum Number of 55 November 25, 1983